Challenges of Targeting Cytokines in MS: Stephanie Blandford, MSc
March 21st 2021The PhD candidate at the neuroimmunology laboratory at Memorial University of Newfoundland discussed the potential of interleukin-1 receptor antagonist as a biomarker in MS disability as well as a therapeutic target.